Terms: = Liver cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
11 results:
1. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract] [Full Text] [Related]
2. Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma.
Hiromatsu M; Toshida K; Itoh S; Harada N; Kohashi K; Oda Y; Yoshizumi T
Ann Surg Oncol; 2023 Dec; 30(13):8675-8689. PubMed ID: 37548836
[TBL] [Abstract] [Full Text] [Related]
3. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
Hou Y; Liang HL; Yu X; Liu Z; Cao X; Rao E; Huang X; Wang L; Li L; Bugno J; Fu Y; Chmura SJ; Wu W; Luo SZ; Zheng W; Arina A; Jutzy J; McCall AR; Vokes EE; Pitroda SP; Fu YX; Weichselbaum RR
Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627484
[TBL] [Abstract] [Full Text] [Related]
4. High activity and low toxicity of a novel cd71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
[TBL] [Abstract] [Full Text] [Related]
5. Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
Xiao C; Fu X; Wang Y; Liu H; Jiang Y; Zhao Z; You F
PLoS One; 2020; 15(12):e0243812. PubMed ID: 33351833
[TBL] [Abstract] [Full Text] [Related]
6. Estrogen-induced epigenetic silencing of
Muhammad JS; Bajbouj K; Shafarin J; Hamad M
Epigenetics; 2020 Dec; 15(12):1302-1318. PubMed ID: 32476555
[TBL] [Abstract] [Full Text] [Related]
7. Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation.
Asperti M; Stuemler T; Poli M; Gryzik M; Lifshitz L; Meyron-Holtz EG; Vlodavsky I; Arosio P
PLoS One; 2016; 11(10):e0164183. PubMed ID: 27711215
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.
Kindrat I; Tryndyak V; de Conti A; Shpyleva S; Mudalige TK; Kobets T; Erstenyuk AM; Beland FA; Pogribny IP
Oncotarget; 2016 Jan; 7(2):1276-87. PubMed ID: 26657500
[TBL] [Abstract] [Full Text] [Related]
9. The role of iron in alcohol-mediated hepatocarcinogenesis.
Mueller S; Rausch V
Adv Exp Med Biol; 2015; 815():89-112. PubMed ID: 25427903
[TBL] [Abstract] [Full Text] [Related]
10. Antiproliferative activity and therapeutic implications of potassium tris(4-methyl-1-pyrazolyl) borohydride in hepatocellular carcinoma.
Jin H; Xu Z; Li D; Huang J
Chem Biol Interact; 2014 Apr; 213():69-76. PubMed ID: 24412237
[TBL] [Abstract] [Full Text] [Related]
11. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
[TBL] [Abstract] [Full Text] [Related]
